NCT06241079View on ClinicalTrials.gov

Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma

CompletedOBSERVATIONAL
Enrollment

582

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

April 28, 2022

Study Completion Date

February 1, 2023

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
OTHER

non-intervention

non-intervention

All Listed Sponsors
collaborator

Chinese Academy of Medical Sciences

OTHER

collaborator

Sichuan Cancer Hospital and Research Institute

OTHER

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER

NCT06241079 - Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter